Vir Biotechnology Inc. (VIR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Vir Biotechnology Inc.

NASDAQ: VIR · Real-Time Price · USD
5.73
0.07 (1.24%)
At close: Oct 03, 2025, 3:59 PM
5.79
1.05%
After-hours: Oct 03, 2025, 07:51 PM EDT

Vir Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
222.95M 241.58M 848.63M 347.81M
Short-Term Investments
678.05M 1.28B 1.55B 360.33M
Long-Term Investments
190.01M 105.28M 23.93M 201.39M
Other Long-Term Assets
18.42M 18.86M -228.5M -87.07M
Receivables
5.1M n/a n/a 773.08M
Inventory
n/a n/a n/a 8.59M
Other Current Assets
46.98M 65.82M 59.2M 8.59M
Total Current Assets
1.04B 1.59B 2.52B 1.56B
Property-Plant & Equipment
122.86M 167.2M 188.17M 130.05M
Goodwill & Intangibles
25.06M 39.5M 49.69M 50.22M
Total Long-Term Assets
356.36M 330.83M 283.01M 391.45M
Total Assets
1.4B 1.92B 2.8B 1.95B
Account Payables
5.08M 6.33M 6.42M 6.52M
Deferred Revenue
12.65M 64.85M 15.52M 98.21M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
16.06M 9.35M 7.65M 96.83M
Total Current Liabilities
119.66M 175.41M 511.03M 341.24M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
38.63M 40.22M 32.8M 25.36M
Total Long-Term Liabilities
128.77M 153.42M 213.1M 181.18M
Total Liabilities
248.43M 328.82M 724.13M 522.42M
Total Debt
97.89M 124.54M 127.97M 133.56M
Book Value
1.15B 1.59B 2.08B 1.43B
Book Value Per Share
8.44 11.86 15.67 11.02
Common Stock
14K 13K 13K 13K
Retained Earnings
-759.78M -237.82M 377.24M -138.6M
Comprehensive Income
-1.72M -815K -9.12M -1.1M
Shareholders Equity
1.15B 1.59B 2.08B 1.43B
Total Investments
868.07M 1.39B 1.55B 561.72M